NLRP3 and Sepsis: RG100204 reduced cardiac and renal dysfunction, decreased activation of the NLRP3 inflammasome pathway and reduced myeloperoxidase activity in lung tissue, suggesting that AQP9 is a potential drug target for polymicrobial sepsis (55).